Latest Articles
-
What’s Next For Pfizer Stock After A Mixed Q1?
Pfizer stock (NYSE: PFE) recently reported its Q1 results, with revenues missing and earnings exceeding the street estimates. The company reported revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to the consensus estima...
-
How Will Pfizer Stock React To Its Upcoming Earnings?
Pfizer (NYSE:PFE) is scheduled to report earnings on Tuesday, April 29, 2025. Looking at PFE’s five-year history, the stock has shown an exact 50-50 split between positive and negative returns following earnings announcements. When positive...
-
What’s Next For PFE Stock After An Upbeat Q4?
Pfizer stock (NYSE: PFE) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $17.8 billion and adjusted earnings of $0.63 per share, compared to the consensus estimates of $...
-
What’s In Store For PFE Stock In 2025?
Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli Lilly stock (up 31%) and AbbVie stock (up 15%), ...
-
What’s Next For Pfizer Stock?
Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 billion, and its adjusted earnings to be in the ran...
-
What’s Behind The 50% Fall In Pfizer Stock?
Pfizer stock (NYSE: PFE) is down 7% in a month, amid rising concerns over the future of vaccines under Robert F. Kennedy Jr. in the new government, given the perception of him being a prominent anti-vaccine activist. Pfizer has had its own issu...
-
What Trends Will Drive Pfizer’s Q3?
Pfizer (NYSE: PFE) is scheduled to report its Q3 2024 results on Tuesday, October 29. We expect the company to post revenue of $15.1 billion and earnings of $0.63 on a per share and adjusted basis, slightly above the consensus estimates of $14.9 ...
-
Will Pfizer Stock See Higher Levels?
Pfizer stock (NYSE: PFE) currently trades at $29 per share, 45% below its peak level of $54 seen in December 2021. In contrast, Merck stock (NYSE:MRK) is up 54% over this period. PFE stock was trading at $47 in early June 2022, just before th...
-
2x Returns Possible For Pfizer Stock?
Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years? Does this sound a bit ridiculous? Consider this – Pfizer stock was trading...
-
Is Pfizer Stock A Better Pick Over AbbVie?
Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock (NYSE:ABBV). PFE stock trades at a much lower multiple of 11x forward, versus 20x for ABBV, and we think thi...
-
Was Q2 The Turning Point For Pfizer Stock?
With Pfizer’s sales rising in Q2, despite falling sales of Covid-19 products, we think that it may well be the turning point for Pfizer stock (NYSE:PFE). It has seen a decline of 15% from levels of $35 in early January 2021 to around $30 ...
-
Will Pfizer Stock Post A Downbeat Q2?
Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $12.95 billion and earnings of $0.44 on a per share and adjusted basis, lower than the consensus estimates. The company is...
-
Pfizer vs. Eli Lilly Stock – Which Is A Better Pick?
We believe that Eli Lilly stock (NYSE: LLY) is currently a better pick than its industry peer – Pfizer stock (NYSE:PFE), given its better prospects. PFE stock trades at a much lower multiple of 2.8x revenues, versus 23.5x for LLY, and we thin...
-
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Pfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. In contrast, Merck stock (NYSE:MRK) is up 36% over this period. PFE stock was trading at $52 in early June 2022, just before the ...
-
Is Pfizer Stock Fully Valued At $28?
Pfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates. The company reported revenue of $14.9 billion and an adjusted profit of $0.82 per share, compared to the consensus estimates of $14.0...
